Drug Development Solutions

  1. HyClone Cell Boost 1 Supplement 9/21/2020

    Improve productivity and cell growth in fed-batch cultures by supplementing the cell culture medium to boost nutrients depleted during culture. HyClone™ Cell Boost™ 1 Supplement provides nutrients such as amino acids and glucose that are suitable for research and bioprocessing applications.

  2. High Resolution Mass Spectrometric Analysis Of Complex Biotherapeutics 5/7/2025

    Understand why continued research and collaboration between industry and regulatory bodies are essential to define guidelines that ensure safety and efficacy in this rapidly advancing field.

  3. PBPK Predictive Modeling Services

    Early identification of potential absorption risks is critical for rapid and efficient drug development. Lonza's PBPK modeling services are designed to de-risk your drug development program.

  4. A Scalable, Benchtop Mixing System For Sensitive Fluids 11/3/2025

    Examine a scalable, benchtop mixing system designed for sensitive fluids and GxP environments that supports automated control, traceability, and compliance from early development through production.

  5. AAV Production: Your AAV CDMO Partner, Every Batch, Every Milestone 6/17/2025

    Confidently navigate every stage of development with tailored tech transfer solutions backed by AAV expertise. Discover how to de-risk, scale, and optimize your process for high-quality performance.

  6. Psychedelics: Drug Development Capabilities 10/30/2023

    Learn how harnessing a CDMO’s extensive knowledge and skills in dealing with controlled substances can help you advance your innovative psychedelic therapeutic safely and efficiently.

  7. Customized CMC Solutions

    Leverage customizable CMC solutions to address unique developmental challenges and propel your molecule toward IND filing and beyond, ensuring an efficient transition to the next stage of development.

  8. Testing Solutions For Antibody-Based Products 4/22/2024

    Explore our suite of analytical testing services for antibody-based drugs, encompassing feasibility studies, method development, validation, routine testing, and stability assessments, all aligned with rigorous regulatory standards.

  9. Our Site Pfizer Ascoli: Oral Solid Dose 12/23/2025

    ASCOLI 2072 represents our long-term, forward-looking vision and our commitment to the sustainable future of our site. It guides how we think, how we act, and how we make decisions every day.

  10. Microbiology Testing: Health Inspired, Quality Driven 4/22/2024

    Whether driven by regulatory mandates or the need to maintain sterility, our services can assist you in meeting these requirements efficiently and accurately, thereby safeguarding patient well-being.